![](/img/cover-not-exists.png)
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
Balbi, Gustavo Guimarães Moreira, Pacheco, Marcelo de Souza, Monticielo, Odirlei Andre, Funke, Andreas, Danowski, Adriana, Santiago, Mittermayer Barreto, Staub, Henrique Luiz, Rêgo, Jozelia, de AndrVolume:
60
Journal:
Advances in Rheumatology
DOI:
10.1186/s42358-020-00125-9
Date:
December, 2020
File:
PDF, 645 KB
2020